During the past decade, Advanced Research Institute, Inc. conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 37 clinical trials were completed, i.e. on average, 94.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Research Institute, Inc." #1 sponsor was "Gilead Sciences" with 12 trials, followed by "Ferring Pharmaceuticals" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Abbott" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Research Institute, Inc." #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Dr. Falk Pharma GmbH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Immunex Corporation" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Research Institute, Inc." are "Prostate Cancer" (9 trials), "Ulcerative Colitis" (6 trials), "Chronic Hepatitis C" (4 trials), "Crohn's Disease" (4 trials) and "Hepatitis C, Chronic" (4 trials). Many other conditions were trialed in "Advanced Research Institute, Inc." in a lesser frequency.

Most popular intervention types in "Advanced Research Institute, Inc." are "Drug" (71 trials), "Biological" (3 trials), "Procedure" (3 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "RBV" (7 trials), "Sofosbuvir" (4 trials), "Etrasimod" (3 trials) and "Etrolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Research Institute, Inc." are 61 trials for "All" genders, 16 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Advanced Research Institute, Inc.". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Advanced Research Institute, Inc., undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Research Institute, Inc., 4 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".